Preparation of Patients for Elective Percutaneous Coronary Intervention: Management of Risk Factors as an Approach to Increase in Intervention Efficacy-Reference-Cited by-同舟云学术

Preparation of Patients for Elective Percutaneous Coronary Intervention: Management of Risk Factors as an Approach to Increase in Intervention Efficacy

Published:2019-09-01 Issue:3 Volume:2 Page:100-109
ISSN:2544-9818
Container-title:Medical University
language:en
Short-container-title:

Author:

Kochergina A.¹²,Leonova V.¹,Kochergin N.²,Barbarash O.¹²

Affiliation:

1. Kemerovo State Medical University , Kemerovo , Russia

2. Federal State Budgetary Scientific Research Institute for Complex Issues of Cardiovascular Diseases , Kemerovo , Russia

Abstract

Abstract The article is a topical literature review of the place of percutaneous coronary interventions in the structure of elective revascularisation procedures, preoperative preparation of patients with stable ischaemic heart disease before percutaneous coronary intervention, the prospects of the technique, taking into account the latest advances in intervention cardiology (intravascular methods for assessing the hemodynamic significance of stenosis, drug eluting stents). Modern data of the early and long-term results of percutaneous coronary intervention are presented, the predictable potentially modifiable risks of adverse events are described, and ways to correct them are discussed. The results of randomised studies comparing the effectiveness of different approaches for managing patients with stable coronary heart disease (medical therapy, percutaneous coronary intervention) are presented, and prospects for using new drugs to improve the early and late outcomes of endovascular revascularisation are discussed.

Publisher

Krasnoyarsk State Medical University

Reference56 articles.

1. 1. Petrosyan KV. Report on the scientific and practical work of the Department of X-ray surgical methods for the study and treatment of heart and vascular diseases for 2018. Byulleten’ NTSSSKH im. A.N. Bakuleva RAMN. Serdechno-sosudistyye zabolevaniya. 2019;20(5):427–33. Russian. https://doi.org/10.24022/1810-0694-2019-20-5-427-43310.24022/1810-0694-2019-20-5-427-433

2. 2. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery. Eur Heart J. 2013;34:2949–3003. https://doi.org/10.1093/eurheartj/eht29610.1093/eurheartj/eht296

3. 3. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. https://doi.org/10.1093/eurheartj/ehy39410.1093/eurheartj/ehy394

4. 4. Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med. 2015;372 (13):1204–12. https://doi.org/10.1056/NEJMoa141544710.1056/NEJMoa1415447

5. 5. Makikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743–52. https://doi.org/10.1016/S0140-6736(16)32052-910.1016/S0140-6736(16)32052-9